Towards Cost-effective Strategies for Treatment of Chronic Kidney Disease-Mineral and Bone Disorder in Japan
Author:
Publisher
Wiley
Subject
Nephrology,Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1744-9987.2009.00771.x/fullpdf
Reference55 articles.
1. An overview of dialysis treatment in Japan (as of 31 Dec. 2007);Nakai;J Jpn Soc Dial Ther,2009
2. Japan's aging population. Implications for healthcare;Oliver;Pharmacoeconomics,1997
3. Overview of regular dialysis treatment in Japan as of 31 December 2006;Nakai;Ther Apher Dial,2008
4. Report of the Asian Forum of Chronic Kidney Disease Initiative (AFCKDI) 2007. “Current status and perspective of CKD in Asia”: diversity and specificity among Asian countries;Tsukamoto;Clin Exp Nephrol,2009
5. The organization and financing of end-stage renal disease treatment in Japan;Fukuhara;Int J Health Care Finance Econ,2007
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A systematic review of the economic evaluations of non-calcium-containing phosphate binders, sevelamer and Lanthanum, in end-stage renal disease patients with hyperphosphatemia;Expert Review of Pharmacoeconomics & Outcomes Research;2019-01-21
2. Economic evaluations of interventions to manage hyperphosphataemia in adult haemodialysis patients: A systematic review;Nephrology;2016-01-28
3. Cost-Effectiveness of Cinacalcet Hydrochloride for Hemodialysis Patients With Severe Secondary Hyperparathyroidism in Japan;American Journal of Kidney Diseases;2012-08
4. Serum cystatin C as a marker for early detection of chronic kidney disease and grade 2 nephropathy in Japanese patients with type 2 diabetes;Clinical Chemistry and Laboratory Medicine;2012-01-01
5. Cost-Effectiveness of Lanthanum Carbonate versus Sevelamer Hydrochloride for the Treatment of Hyperphosphatemia in Patients with End-Stage Renal Disease: A US Payer Perspective;Value in Health;2011-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3